Aceclofenac 200 mg + Pregabalin 75 mg Enteric-Coated Tablet

Aceclofenac 200 mg + Pregabalin 75 mg Enteric-Coated Tablet is a enteric-coated tablet formulated with Aceclofenac 200 mg + Pregabalin 75 mg. The active ingredient profile is Aceclofenac; Pregabalin, placing the product in the nsaid + neuropathic pain agent combination category. The formulation combines an anti-inflammatory analgesic with Pregabalin, a medicine used in selected neuropathic-pain settings, so the exact fixed-dose indication should be label-led. The enteric coating is intended to delay tablet disintegration until after passage through the stomach, subject to the approved finished-product specification. For website cataloguing, composition, strength, dosage form and release/coating characteristics should be displayed prominently and consistently. The description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and the prescriber’s judgement. Prescription status, precautions, interactions, adverse effects and dosing must be checked against the current approved product label before publication. Manufacturer, licence, storage, shelf-life, pack configuration and market-specific regulatory details should be added only from verified product documentation.